AN OPEN-LABEL, RANDOMIZED, ACTIVE-CONTROLLED, PARALLEL GROUP, MULTICENTRE PHASE 3 STUDY TO INVESTIGATE THE LONG TERM SAFETY, TOLERABILITY AND EFFICACY OF PA21 COMPARED WITH SEVELAMER CARBONATE IN DIALYSIS PATIENTS WITH
Principal Investigator(s)
Qunibi,Wajeh Y
Funded by
VIFOR PHARMA LTD.
Research Start Date
Status
Inactive